ArticleHaematologica2024

Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.

Mehmet H Kocoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.